Skip to main content

Table 5 Multivariate logistic regression analysis of clinical parameters in PCOS patients complicated with cardiovascular disease

From: Correlation study on serum miR-222-3p and glucose and lipid metabolism in patients with polycystic ovary syndrome

 

PCOS non-ow

 

PCOS ow

P

OR (95% CI)

P

OR (95% CI)

Age

0.278

0.748 (0.442–1.264)

Age

0.632

1.274 (0.473–3.426)

BMI

0.473

0.884 (0.631–1.238)

BMI

0.358

0.724 (0.364–1.441)

FPG

0.405

0.145 (0.002–13.675)

FPG

0.272

3.822 (0.349–41.847)

HbA1c

0.475

1.617 (0.433–6.038)

HbA1c

0.339

3.942 (0.237–65.454)

FINS

0.215

0.223 (0.021–2.386)

FINS

0.519

7.930 (0.015–4283.911)

HOMA-IR

0.298

1.108 (0.607–2.025)

HOMA-IR

0.325

1.481 (0.678–3.236)

TG

0.469

0.711 (0.283–1.789)

TG

0.960

1.039 (0.239–4.514)

TC

0.044

3.173 (1.029–9.78)

TC

0.043

23.825 (1.099–516.505)

LDL-C

0.409

0.482 (0.085–2.724)

LDL-C

0.162

8.385 (0.426–165.198)

HDL-C

0.964

0.937 (0.055–16.031)

HDL-C

0.816

1.805 (0.012–261.406)

LH

0.090

0.74 (0.523–1.048)

LH

0.317

0.623 (0.246–1.575)

FSH

0.575

0.797 (0.36–1.764)

FSH

0.383

0.647 (0.243–1.722)

T

0.084

0.923 (0.843–1.011)

T

0.799

1.013 (0.92–1.115)

SHBG

0.198

0.961 (0.906–1.021)

SHBG

0.907

1.012 (0.834–1.227)

PRL

0.832

1.000 (0.997–1.004)

PRL

0.577

1.003 (0.994–1.011)

E2

0.859

0.995 (0.939–1.054)

E2

0.438

1.057 (0.919–1.216)

miR-222-3p

0.005

79.390 (3.77–1671.674)

miR-222-3p

0.038

45.771 (1.234–1697.185)

  1. PCOS polycystic ovary syndrome, ow overweight, BMI body mass index, FPG fasting plasma glucose, FINS fasting insulin, HOMA-IR homeostatic model assessment–insulin resistance, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LH luteinizing hormone, FSH follicle-stimulating hormone, T testosterone, SHBG sex hormone-binding globulin, PRL prolactin, E2 estradiol, miR microRNA